))
CAPSTONE: An Exagen Podcast
Segna tutti come (non) riprodotti ...
Serie archiviate ("Feed non attivo" status)
When?
This feed was archived on February 27, 2024 01:29 (
Why? Feed non attivo status. I nostri server non sono riusciti a recuperare un feed valido per un periodo prolungato.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage series 3369590
Contenuto fornito da Exagen Podcast. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Exagen Podcast o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
The CAPSTONE study is the largest ever comparative utility study in lupus diagnostics. But why was the study necessary to conduct? What did the process look like? And what do the results prove? Answering these questions are our two interviewees: Dr. Debra Zack, Chief Medical Officer for Exagen and Tyler O’Malley, Director of Evidence Development for Exagen and co-author of the study. Join them on this four-part journey as they explore the unmet need that prompted the study, the conclusive results from the study, and what these discoveries mean for both patients and providers.
…
continue reading
4 episodi
Condividi
